Literature DB >> 10851381

Status epilepticus associated with cefepime.

S Dixit1, P Kurle, L Buyan-Dent, R D Sheth.   

Abstract

Cefepime is a fourth-generation cephalosporin widely used for gram-negative sepsis. The authors report two patients in whom nonconvulsive status epilepticus developed while they were on treatment with cefepime for Pseudomonas aeruginosa infection. The status epilepticus resolved completely once the drug was withdrawn. Cefepime therapy can result in status epilepticus, especially if given in higher doses than required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851381     DOI: 10.1212/wnl.54.11.2153

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Cefepime neurotoxicity can mimic postanoxic coma with myoclonic status epilepticus.

Authors:  Nitin K Sethi
Journal:  Neurol Clin Pract       Date:  2012-03

2.  Cefepime-Associated SIRPIDs in a Patient With Normal Renal Function.

Authors:  Emily Johnson; Yousef Hannawi; Nirma Carballido Martinez; Eva K Ritzl
Journal:  Neurohospitalist       Date:  2015-10-14

3.  Prospective monitoring of cefepime in intensive care unit adult patients.

Authors:  Thomas M Chapuis; Eric Giannoni; Paul A Majcherczyk; René Chioléro; Marie-Denise Schaller; Mette M Berger; Saskia Bolay; Laurent A Décosterd; Denis Bugnon; Philippe Moreillon
Journal:  Crit Care       Date:  2010-04-01       Impact factor: 9.097

4.  Non-convulsive status epilepticus following antibiotic therapy as a cause of unexplained loss of consciousness in patients with renal failure.

Authors:  Savas Ozturk; Gonenc Kocabay; Baris Topcular; Halil Yazici; Arif Atahan Cagatay; Gulistan Bahat; Betul Baykan; Aydin Turkmen; Alaattin Yildiz
Journal:  Clin Exp Nephrol       Date:  2008-12-17       Impact factor: 2.801

5.  Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function.

Authors:  Vincent H Tam; Peggy S McKinnon; Ronda L Akins; George L Drusano; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 6.  Cefepime-induced nonconvulsive status epilepticus: case report and review.

Authors:  Farah Thabet; Mohamed Al Maghrabi; Ahmed Al Barraq; Brahim Tabarki
Journal:  Neurocrit Care       Date:  2008-11-25       Impact factor: 3.210

7.  Cefepime-induced non-convulsive status epilepticus in a peritoneal dialysis patient.

Authors:  Harika Alpay; Ozge Altun; Nese Karaaslan Biyikli
Journal:  Pediatr Nephrol       Date:  2004-02-21       Impact factor: 3.714

8.  Clinical, Electroencephalographic Features and Prognostic Factors of Cefepime-Induced Neurotoxicity: A Retrospective Study.

Authors:  Han-Tao Li; Chih-Hong Lee; Tony Wu; Mei-Yun Cheng; Wei-En Johnny Tseng; Chun-Wei Chang; Hsiang-Yao Hsieh; Hsing-I Chiang; Chih-Yin Lin; Bao-Luen Chang; Wey-Ran Lin; Siew-Na Lim
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

Review 9.  Cefepime-induced neurotoxicity: a systematic review.

Authors:  Lauren E Payne; David J Gagnon; Richard R Riker; David B Seder; Elizabeth K Glisic; Jane G Morris; Gilles L Fraser
Journal:  Crit Care       Date:  2017-11-14       Impact factor: 9.097

10.  Looking beyond the Obvious: Cefepime-induced Nonconvulsive Status Epilepticus.

Authors:  Vinayaka Anuhya; Sushil Kiran Kunder; Sharath Madhyastha; Veena Nayak; Raviraja V Acharya; Kusugodlu Ramamoorthi; Avinash Arivazhahan; Rahul Sai Gangula
Journal:  J Pharmacol Pharmacother       Date:  2017 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.